Deutsch
A A A
DE
Bereichsnavigation

Previous
RHÖN-KLINIKUM AG | 05/15/2020

B. Braun Melsungen AG requests supplements to agenda of the extraordinary general shareholders' meeting on 3 June 2020

On 14 May 2020, the Management Board of RHÖN-KLINIKUM Aktiengesellschaft has received a request by the shareholder B. Braun Melsungen AG ("B. Braun") for supplements to the agenda of the extraordinary general shareholders' meeting on 3 June 2020. According to the request for supplements, B. Braun demands the following additional items be put on the agenda:

  • presentation of the adopted annual financial statements and the approved consolidated financial statements as of 31 December 2019 (including management reports and report of the Supervisory Board for the 2019 financial year),
  • resolution on the appropriation of the balance sheet profit, whereby B. Braun leaves it to the Management Board and the Supervisory Board to submit the proposal for the appropriation of profit published in the 2019 Annual Report,
  • resolution on the discharge of the members of the Management Board and the shareholder representatives on the Supervisory Board for the 2019 financial year, and
  • election of the shareholder representatives on the Supervisory Board, whereby it is proposed that the candidates already proposed by B. Braun in the request to convene the meeting shall be elected for the maximum term of office permitted by law.

The Management Board will diligently examine B. Braun's request for supplements and take the legally required measures.

------------------------------------

RHÖN‐KLINIKUM AG is one of the largest healthcare providers in Germany. The hospital group offers excellent medical care with a direct link to universities and research institutes. Over 860,000 patients are treated every year at the five group hospitals located in Bad Berka, Bad Neustadt, Frankfurt (Oder), Giessen and Marburg where more than 18,000 employees work. RHÖN-KLINIKUM AG is currently exploiting the opportunities available to develop new areas of growth. Entering the forward-looking telemedicine market with Medgate Deutschland, the innovative RHÖN campus concept for offering avantgarde healthcare across sectoral boundaries in rural areas as well as consistently extending our gradual corporate digitalisation are key pillars of the corporate strategy.

More information under www.rhoen-klinikum-ag.com

Follow us

www.twitter.com/rhoenklinikumag
www.xing.com/companies/rhön-klinikumag
www.youtube.com/rhönklinikumag

Contact Persons:

RHÖN-KLINIKUM AG | Head of Corporate Communications and Marketing
Elke Pfeifer
Telephone: +49 9771 65-12110 | E-Mail: elke.pfeifer(at)rhoen-klinikum-ag.com

RHÖN-KLINIKUM AG | Schlossplatz 1 | 97616 Bad Neustadt / Saale, Germany